乳腺癌中西医结合诊疗共识

2021-07-09 中国中西医结合学会 中国医学前沿杂志(电子版)

本共识由中医、中西医结合、乳腺内科、外科、放疗等多个乳腺癌领域的专家基于循证医学证据编写而成,经过3次专家讨论会,最终修订成文。现代中医强调辨证辨病、中西医融合治疗,而乳腺癌精准治疗同样指导中医的临床

中文标题:

乳腺癌中西医结合诊疗共识

发布机构:

中国中西医结合学会

发布日期:

2021-07-09

简要介绍:

本共识由中医、中西医结合、乳腺内科、外科、放疗等多个乳腺癌领域的专家基于循证医学证据编写而成,经过3次专家讨论会,最终修订成文。现代中医强调辨证辨病、中西医融合治疗,而乳腺癌精准治疗同样指导中医的临床实践,中医的辨证论治与乳腺癌分子分型结合将会丰富中医个体化治疗的内涵。

相关资料下载:
[AttachmentFileName(sort=1, fileName=乳腺癌中西医结合诊疗共识.pdf)] GetToolGuiderByIdResponse(projectId=1, id=296031c00212954c, title=乳腺癌中西医结合诊疗共识, enTitle=, guiderFrom=中国医学前沿杂志(电子版) , authorId=0, author=, summary=本共识由中医、中西医结合、乳腺内科、外科、放疗等多个乳腺癌领域的专家基于循证医学证据编写而成,经过3次专家讨论会,最终修订成文。现代中医强调辨证辨病、中西医融合治疗,而乳腺癌精准治疗同样指导中医的临床, cover=https://img.medsci.cn/2021715/1626285094466_2020535.jpg, journalId=0, articlesId=null, associationId=759, associationName=中国中西医结合学会, associationIntro=中国中西医结合学会是中西医结合医学科学技术工作者组成的学术性群众团体,是依法成立的社团法人,是中国科学技术协会的团体会员。, copyright=0, guiderPublishedTime=Fri Jul 09 00:00:00 CST 2021, originalUrl=, linkOutUrl=, content=<div class="one_info2" style="color: #373737;"> <div id="all_content"> <div class="editor_mirror editor_mirror_del"> <p>本共识由中医、中西医结合、乳腺内科、外科、放疗等多个乳腺癌领域的专家基于循证医学证据编写而成,经过3次专家讨论会,最终修订成文。现代中医强调辨证辨病、中西医融合治疗,而乳腺癌精准治疗同样指导中医的临床实践,中医的辨证论治与乳腺癌分子分型结合将会丰富中医个体化治疗的内涵。</p> </div> </div> </div>, tagList=[TagDto(tagId=285, tagName=乳腺癌)], categoryList=[CategoryDto(categoryId=5, categoryName=肿瘤科, tenant=100), CategoryDto(categoryId=37, categoryName=中医科, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=89, categoryName=乳腺癌, tenant=100), CategoryDto(categoryId=20620, categoryName=肿瘤医学网, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=285, guiderKeyword=乳腺癌, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=共识, guiderLanguage=0, guiderRegion=3, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=19995, appHits=275, showAppHits=0, pcHits=897, showPcHits=19720, likes=2, shares=23, comments=16, approvalStatus=1, publishedTime=Thu Jul 15 01:51:49 CST 2021, publishedTimeString=2021-07-09, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=2, createdBy=null, createdName=qiushida2, createdTime=Thu Jul 15 01:51:44 CST 2021, updatedBy=2020535, updatedName=qiushida2, updatedTime=Sat Jan 06 18:51:33 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=乳腺癌中西医结合诊疗共识.pdf)])
乳腺癌中西医结合诊疗共识.pdf
下载请点击:
评论区 (13)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1207080, encodeId=f0e3120e080c7, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2ae16241095, createdName=56446_2968, createdTime=Wed Mar 30 05:38:51 CST 2022, time=2022-03-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1192477, encodeId=789b11924e7d0, content=非常实用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=89ae6481716, createdName=ms3000000637975859, createdTime=Fri Feb 11 21:55:18 CST 2022, time=2022-02-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1186587, encodeId=24e7118658ec8, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=30236476956, createdName=ms5000000854890707, createdTime=Thu Jan 20 20:59:46 CST 2022, time=2022-01-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1076577, encodeId=8a0510e6577ec, content=期望的专业权威资料!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=46916162545, createdName=ms7000000729645787, createdTime=Fri Dec 03 15:40:53 CST 2021, time=2021-12-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1057026, encodeId=c3d4105e02691, content=非常棒, beContent=null, objectType=guider, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=54a65624383, createdName=ms1000001086816093, createdTime=Sun Oct 03 06:55:58 CST 2021, time=2021-10-03, status=1, ipAttribution=)]
    2022-03-30 56446_2968

    学习

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1207080, encodeId=f0e3120e080c7, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2ae16241095, createdName=56446_2968, createdTime=Wed Mar 30 05:38:51 CST 2022, time=2022-03-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1192477, encodeId=789b11924e7d0, content=非常实用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=89ae6481716, createdName=ms3000000637975859, createdTime=Fri Feb 11 21:55:18 CST 2022, time=2022-02-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1186587, encodeId=24e7118658ec8, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=30236476956, createdName=ms5000000854890707, createdTime=Thu Jan 20 20:59:46 CST 2022, time=2022-01-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1076577, encodeId=8a0510e6577ec, content=期望的专业权威资料!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=46916162545, createdName=ms7000000729645787, createdTime=Fri Dec 03 15:40:53 CST 2021, time=2021-12-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1057026, encodeId=c3d4105e02691, content=非常棒, beContent=null, objectType=guider, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=54a65624383, createdName=ms1000001086816093, createdTime=Sun Oct 03 06:55:58 CST 2021, time=2021-10-03, status=1, ipAttribution=)]
    2022-02-11 ms3000000637975859

    非常实用

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1207080, encodeId=f0e3120e080c7, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2ae16241095, createdName=56446_2968, createdTime=Wed Mar 30 05:38:51 CST 2022, time=2022-03-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1192477, encodeId=789b11924e7d0, content=非常实用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=89ae6481716, createdName=ms3000000637975859, createdTime=Fri Feb 11 21:55:18 CST 2022, time=2022-02-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1186587, encodeId=24e7118658ec8, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=30236476956, createdName=ms5000000854890707, createdTime=Thu Jan 20 20:59:46 CST 2022, time=2022-01-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1076577, encodeId=8a0510e6577ec, content=期望的专业权威资料!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=46916162545, createdName=ms7000000729645787, createdTime=Fri Dec 03 15:40:53 CST 2021, time=2021-12-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1057026, encodeId=c3d4105e02691, content=非常棒, beContent=null, objectType=guider, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=54a65624383, createdName=ms1000001086816093, createdTime=Sun Oct 03 06:55:58 CST 2021, time=2021-10-03, status=1, ipAttribution=)]
    2022-01-20 ms5000000854890707

    学习学习

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1207080, encodeId=f0e3120e080c7, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2ae16241095, createdName=56446_2968, createdTime=Wed Mar 30 05:38:51 CST 2022, time=2022-03-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1192477, encodeId=789b11924e7d0, content=非常实用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=89ae6481716, createdName=ms3000000637975859, createdTime=Fri Feb 11 21:55:18 CST 2022, time=2022-02-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1186587, encodeId=24e7118658ec8, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=30236476956, createdName=ms5000000854890707, createdTime=Thu Jan 20 20:59:46 CST 2022, time=2022-01-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1076577, encodeId=8a0510e6577ec, content=期望的专业权威资料!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=46916162545, createdName=ms7000000729645787, createdTime=Fri Dec 03 15:40:53 CST 2021, time=2021-12-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1057026, encodeId=c3d4105e02691, content=非常棒, beContent=null, objectType=guider, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=54a65624383, createdName=ms1000001086816093, createdTime=Sun Oct 03 06:55:58 CST 2021, time=2021-10-03, status=1, ipAttribution=)]
    2021-12-03 ms7000000729645787

    期望的专业权威资料!

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1207080, encodeId=f0e3120e080c7, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2ae16241095, createdName=56446_2968, createdTime=Wed Mar 30 05:38:51 CST 2022, time=2022-03-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1192477, encodeId=789b11924e7d0, content=非常实用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=89ae6481716, createdName=ms3000000637975859, createdTime=Fri Feb 11 21:55:18 CST 2022, time=2022-02-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1186587, encodeId=24e7118658ec8, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=30236476956, createdName=ms5000000854890707, createdTime=Thu Jan 20 20:59:46 CST 2022, time=2022-01-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1076577, encodeId=8a0510e6577ec, content=期望的专业权威资料!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=46916162545, createdName=ms7000000729645787, createdTime=Fri Dec 03 15:40:53 CST 2021, time=2021-12-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1057026, encodeId=c3d4105e02691, content=非常棒, beContent=null, objectType=guider, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=54a65624383, createdName=ms1000001086816093, createdTime=Sun Oct 03 06:55:58 CST 2021, time=2021-10-03, status=1, ipAttribution=)]
    2021-10-03 ms1000001086816093

    非常棒

    0

拓展阅读

乳腺癌HER2检测指南(2009版)

中国肿瘤科相关专家小组(统称) · 2009-12-01

2010 乳腺癌骨转移和骨相关疾病临床诊疗专家共识(2010版)

乳腺癌骨转移和骨相关疾病临床诊疗专家组 · 2010-01-01

2010 SBI/ACR推荐建议:乳腺癌影像学筛查

乳腺影像学会(SBI,Society of Breast Imaging) · 2010-01-20

2010 人表皮生长因子受体2阳性乳腺癌临床诊疗专家共识

中国抗癌协会乳腺癌专业委员会(CACA-CBCS,Chinese Anti-Cancer Association, Committee of Breast Cancer Society) · 2010-02-01

2010 ASCO-CAP指南:乳腺癌患者雌激素和雄激素受体的免疫组化检测

美国临床肿瘤学会(ASCO,American Society of Clinical Oncology) · 2010-04-19

2010 ASCO指南:激素受体阳性乳腺癌妇女的辅助内分泌治疗

美国临床肿瘤学会(ASCO,American Society of Clinical Oncology) · 2010-07-12